Ratio Therapeutics Raises $70 Million to Advance Radiotherapeutics
BOSTON, July 31, 2026 Ratio Therapeutics announced the successful closing of a $70 million Series C financing, increasing the...
Series C financing
Advertisement
Trellis Raises $9M to Advance Calpurbatug Phase 2 Trial
REDWOOD CITY, Calif., July 16, 2026 Trellis Bioscience has secured $9 million in Series C financing to accelerate the...
Triveni Bio Secures $65M to Advance TRIV-573 Development
WATERTOWN, Mass., June 17, 2026 Triveni Bio, a clinical-stage biotechnology company developing innovative antibody therapies for immunological and inflammatory...
Inquis Medical Raises $75M to Expand AVENTUS Thrombectomy
MENLO PARK, Calif., January 12, 2026 — Inquis Medical, a commercial-stage medical technology company focused on venous thromboembolic disease...
Advertisement
